Dr. Sulaiman Al Habib Medical Services Group
Market Cap
ر.س60.0b
Last Updated
2021/08/01 16:13 UTC
Data Sources
Company Financials +
Executive Summary
Dr. Sulaiman Al Habib Medical Services Group Company develops, owns, and operates hospitals and medical centers. More Details
Rewards
Risk Analysis
Snowflake Analysis
Outstanding track record with adequate balance sheet.
Similar Companies
Share Price & News
How has Dr. Sulaiman Al Habib Medical Services Group's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 4013 is not significantly more volatile than the rest of SA stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: 4013's weekly volatility (3%) has been stable over the past year.
Market Performance
7 Day Return
5.5%
4013
3.5%
SA Healthcare
0.2%
SA Market
1 Year Return
96.6%
4013
80.7%
SA Healthcare
15.0%
SA Market
Return vs Industry: 4013 exceeded the SA Healthcare industry which returned 79% over the past year.
Return vs Market: 4013 exceeded the SA Market which returned 15.1% over the past year.
Shareholder returns
| 4013 | Industry | Market | |
|---|---|---|---|
| 7 Day | 5.5% | 3.5% | 0.2% |
| 30 Day | 7.7% | 5.5% | -0.2% |
| 90 Day | 14.7% | 12.1% | 0.6% |
| 1 Year | 100.6%96.6% | 83.7%80.7% | 19.4%15.0% |
| 3 Year | n/a | 62.5%55.6% | 43.9%31.1% |
| 5 Year | n/a | 53.9%41.5% | 106.6%75.7% |
Long-Term Price Volatility Vs. Market
How volatile is Dr. Sulaiman Al Habib Medical Services Group's share price compared to the market and industry in the last 5 years?
Simply Wall St News
5 hours ago | Simply Wall St
Here's Why I Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Might Deserve Your Attention TodayValuation
Is Dr. Sulaiman Al Habib Medical Services Group undervalued compared to its fair value and its price relative to the market?
53.68x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: 4013 (SAR173) is trading above our estimate of fair value (SAR104.78)
Significantly Below Fair Value: 4013 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: 4013 is poor value based on its PE Ratio (53.7x) compared to the SA Healthcare industry average (42x).
PE vs Market: 4013 is poor value based on its PE Ratio (53.7x) compared to the SA market (33.8x).
Price to Earnings Growth Ratio
PEG Ratio: 4013 is poor value based on its PEG Ratio (8.4x)
Price to Book Ratio
PB vs Industry: 4013 is overvalued based on its PB Ratio (12.1x) compared to the SA Healthcare industry average (2.9x).
Future Growth
How is Dr. Sulaiman Al Habib Medical Services Group forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
6.4%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 4013's forecast earnings growth (6.4% per year) is below the savings rate (8.8%).
Earnings vs Market: 4013's earnings (6.4% per year) are forecast to grow slower than the SA market (6.7% per year).
High Growth Earnings: 4013's earnings are forecast to grow, but not significantly.
Revenue vs Market: 4013's revenue (10.4% per year) is forecast to grow faster than the SA market (3.2% per year).
High Growth Revenue: 4013's revenue (10.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 4013's Return on Equity is forecast to be high in 3 years time (25.4%)
Past Performance
How has Dr. Sulaiman Al Habib Medical Services Group performed over the past 5 years?
5.7%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 4013 has high quality earnings.
Growing Profit Margin: 4013's current net profit margins (18.2%) are higher than last year (17.2%).
Past Earnings Growth Analysis
Earnings Trend: 4013's earnings have grown by 5.7% per year over the past 5 years.
Accelerating Growth: 4013's earnings growth over the past year (27.8%) exceeds its 5-year average (5.7% per year).
Earnings vs Industry: 4013 earnings growth over the past year (27.8%) exceeded the Healthcare industry 23.8%.
Return on Equity
High ROE: 4013's Return on Equity (21.5%) is considered high.
Financial Health
How is Dr. Sulaiman Al Habib Medical Services Group's financial position?
Financial Position Analysis
Short Term Liabilities: 4013's short term assets (SAR4.2B) exceed its short term liabilities (SAR1.9B).
Long Term Liabilities: 4013's short term assets (SAR4.2B) exceed its long term liabilities (SAR2.8B).
Debt to Equity History and Analysis
Debt Level: 4013's debt to equity ratio (46.2%) is considered high.
Reducing Debt: 4013's debt to equity ratio has increased from 25.1% to 46.2% over the past 5 years.
Debt Coverage: 4013's debt is well covered by operating cash flow (88.7%).
Interest Coverage: 4013's interest payments on its debt are well covered by EBIT (37.8x coverage).
Balance Sheet
Dividend
What is Dr. Sulaiman Al Habib Medical Services Group current dividend yield, its reliability and sustainability?
1.21%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 4013's dividend (1.21%) isn’t notable compared to the bottom 25% of dividend payers in the SA market (1.45%).
High Dividend: 4013's dividend (1.21%) is low compared to the top 25% of dividend payers in the SA market (4.14%).
Stability and Growth of Payments
Stable Dividend: Too early to tell whether 4013's dividend payments have been stable as they only just started paying a dividend.
Growing Dividend: Too early to tell if 4013's dividend payments are increasing as they only just started paying a dividend.
Current Payout to Shareholders
Dividend Coverage: With its reasonable payout ratio (71.4%), 4013's dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: 4013's dividends in 3 years are forecast to be covered by earnings (63.9% payout ratio).
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
2.6yrs
Average board tenure
CEO
Nasser Mohammed Al Huqbani
no data
Tenure
ر.س209,000
Compensation
Mr. Nasser Mohammed Abdulaziz Al Huqbani has been Chief Executive Officer and Executive member of Board at Dr. Sulaiman Al Habib Medical Services Group Company since December 10, 2018. Mr. Al Huqbani is a ...
Board Members
Experienced Board: 4013's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Insufficient data to determine if shareholders have been diluted in the past year.
Top Shareholders
Company Information
Dr. Sulaiman Al Habib Medical Services Group Company's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Dr. Sulaiman Al Habib Medical Services Group Company
- Ticker: 4013
- Exchange: SASE
- Founded: 1995
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: ر.س59.990b
- Shares outstanding: 350.00m
- Website: https://www.hmg.com
Number of Employees
Location
- Dr. Sulaiman Al Habib Medical Services Group Company
- King Fahad Road
- Olaya District
- Riyadh
- 11643
- Saudi Arabia
Listings
Biography
Dr. Sulaiman Al Habib Medical Services Group Company develops, owns, and operates hospitals and medical centers. The company operates spinal surgery, vascular, general medicine, urology, dental, diabetes a...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/08/01 16:13 |
| End of Day Share Price | 2021/08/01 00:00 |
| Earnings | 2021/03/31 |
| Annual Earnings | 2020/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.